VX16-809-116: A Phase 3, Rollover Study to Evaluate the Safety of Long term Treatment with Lumacaftor/Ivacaftor Combination Therapy in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutati